BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harvey HB, Gowda V, Cheng G. Gadolinium Deposition Disease: A New Risk Management Threat. Journal of the American College of Radiology 2020;17:546-50. [DOI: 10.1016/j.jacr.2019.11.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Harvey HB, Gowda V, Cheng G. Authors' Reply. J Am Coll Radiol 2020;17:1078-9. [PMID: 32653272 DOI: 10.1016/j.jacr.2020.06.012] [Reference Citation Analysis]
2 Sdogkos E, Xanthopoulos A, Giamouzis G, Skoularigis J, Triposkiadis F, Vogiatzis I. Diagnosis of coronary artery disease: potential complications of imaging techniques. Acta Cardiol 2021;:1-4. [PMID: 33861180 DOI: 10.1080/00015385.2021.1911467] [Reference Citation Analysis]
3 Liu CY, Schöckel L, Habib P, Balzer T, Pietsch H. Re: "Gadolinium Deposition Disease: A New Risk Management Threat". J Am Coll Radiol 2020;17:1077-8. [PMID: 32663450 DOI: 10.1016/j.jacr.2020.06.016] [Reference Citation Analysis]
4 Maecker HT, Siebert JC, Rosenberg-Hasson Y, Koran LM, Ramalho M, Semelka RC. Acute Chelation Therapy-Associated Changes in Urine Gadolinium, Self-reported Flare Severity, and Serum Cytokines in Gadolinium Deposition Disease. Invest Radiol 2021;56:374-84. [PMID: 33449576 DOI: 10.1097/RLI.0000000000000752] [Reference Citation Analysis]
5 Wyskocka-Gajda M, Przypis Ł, Olesiejuk M, Krawczyk T, Kuźnik A, Nawara K, Minoshima M, Sugihara F, Kikuchi K, Kuźnik N. A step towards gadolinium-free bioresponsive MRI contrast agent. Eur J Med Chem 2021;211:113086. [PMID: 33348236 DOI: 10.1016/j.ejmech.2020.113086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kastelik-Hryniewiecka A, Jewula P, Bakalorz K, Kramer-Marek G, Kuźnik N. Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges. Int J Nanomedicine 2021;16:8465-83. [PMID: 35002239 DOI: 10.2147/IJN.S336299] [Reference Citation Analysis]
7 Kartamihardja AAP, Kumasaka S, Hilfi L, Kameo S, Koyama H, Tsushima Y. Biosorption of different gadolinium (Gd) complexes from water by Eichhornia crassipes (water hyacinth). Int J Phytoremediation 2021;:1-9. [PMID: 34613832 DOI: 10.1080/15226514.2021.1984388] [Reference Citation Analysis]
8 Nelson KA, Thaker AA, Callen AL, Albach E, Timpone VM. New-onset seizures in adults: Low diagnostic yield of gadolinium contrast in initial brain MRI evaluation. J Neuroimaging 2021. [PMID: 34110667 DOI: 10.1111/jon.12897] [Reference Citation Analysis]
9 Cox J, Graham Y. Gadolinium use and risks: an update for colleagues in primary care. Br J Gen Pract 2021;71:444-5. [PMID: 34593391 DOI: 10.3399/bjgp21X717125] [Reference Citation Analysis]
10 Kim G, Donohoe K, Smith MP, Hamaguchi R, Johnson AR, Singhal D, Tsai LL. Use of non-contrast MR in diagnosing secondary lymphedema of the upper extremities. Clin Imaging 2021;80:400-5. [PMID: 34534773 DOI: 10.1016/j.clinimag.2021.08.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rogers S, Carreira J, Phair A, Olech C, Ghosh J, McCollum C. Comparison Between Below Knee Contrast Enhanced Tomographic 3D Ultrasound and CT, MR or Catheter Angiography for Peripheral Artery Imaging. Eur J Vasc Endovasc Surg 2021;61:440-6. [PMID: 33229220 DOI: 10.1016/j.ejvs.2020.10.007] [Reference Citation Analysis]
12 Torresan MF, Wolosiuk A. Critical Aspects on the Chemical Stability of NaYF 4 -Based Upconverting Nanoparticles for Biomedical Applications. ACS Appl Bio Mater 2021;4:1191-210. [DOI: 10.1021/acsabm.0c01562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Marks RM, Ash RM, Lee JT. Gadolinium Deposition and Liver MRI. Clin Liver Dis (Hoboken) 2021;17:129-32. [PMID: 33868652 DOI: 10.1002/cld.1024] [Reference Citation Analysis]
14 Elschot EP, Backes WH, Postma AA, van Oostenbrugge RJ, Staals J, Rouhl RPW, Jansen JFA. A Comprehensive View on MRI Techniques for Imaging Blood-Brain Barrier Integrity. Invest Radiol 2021;56:10-9. [PMID: 32932377 DOI: 10.1097/RLI.0000000000000723] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mascalchi M, Sali L. Gadolinium Deposition Disease and T1 Hyperintensity of the Gray Matter Nuclei: An Inconsequential Link. J Am Coll Radiol 2020;17:981. [PMID: 32220578 DOI: 10.1016/j.jacr.2020.01.045] [Reference Citation Analysis]
16 Semelka RC, Ramalho M. Physicians with self-diagnosed gadolinium deposition disease: a case series. Radiol Bras 2021;54:238-42. [PMID: 34393290 DOI: 10.1590/0100-3984.2020.0073] [Reference Citation Analysis]
17 Brisset JC, Vukusic S, Cotton F; Imaging Group of the 'Observatoire francais de la sclérose en plaques'. Update on brain MRI for the diagnosis and follow-up of MS patients. Presse Med 2021;50:104067. [PMID: 33989722 DOI: 10.1016/j.lpm.2021.104067] [Reference Citation Analysis]
18 Yang L, Fu S, Cai Z, Liu L, Xia C, Gong Q, Song B, Ai H. Integration of PEG-conjugated gadolinium complex and superparamagnetic iron oxide nanoparticles as T 1-T 2 dual-mode magnetic resonance imaging probes. Regen Biomater 2021;8:rbab064. [PMID: 34881046 DOI: 10.1093/rb/rbab064] [Reference Citation Analysis]
19 Baranger J, Villemain O, Wagner M, Vargas-Gutierrez M, Seed M, Baud O, Ertl-Wagner B, Aguet J. Brain perfusion imaging in neonates. Neuroimage Clin 2021;31:102756. [PMID: 34298475 DOI: 10.1016/j.nicl.2021.102756] [Reference Citation Analysis]